Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise-Reference-Cited by-同舟云学术

Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise

Published:2012-07-30 Issue:21 Volume:21 Page:4645-4654
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Chamberlain Christopher M.,Ranum Laura P.W.

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/21/21/4645/17256918/dds306.pdf

Reference35 articles.

1. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9;Liquori;Science,2001

2. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member;Brook;Cell,1992

3. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene;Mahadevan;Science,1992

4. An unstable triplet repeat in a gene related to myotonic muscular dystrophy;Fu;Science,1992

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration;International Journal of Molecular Sciences;2024-02-26

2. Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression;Molecular Therapy - Nucleic Acids;2023-12

3. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model;International Journal of Molecular Sciences;2023-02-14

4. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function;Nucleic Acids Research;2023-01-09

5. Molecular Genetic Therapies in the Muscular Dystrophies;Current Clinical Neurology;2023